ORMP

Oramed Pharmaceuticals Inc.

Price

$4.66

return (12m)

107.62%

p/e

1.11

p/bv

0.61

DIVIDEND YIELD

5.30%

ORMP price

Oramed Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ORMP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

4.72%

3 months

21.35%

1 year

107.62%

2 years

100.95%

5 years

-74.27%

10 years

-32.75%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals ORMP

Valuation

P/E

1.11

Sector -3.82

Industry -3.82

P/BV

0.61

Sector 2.08

Industry 2.08

P/Revenue (PSR)

Sector 2.04

Industry 2.04

EV/EBITDA

-52.32

Sector -226.01

Industry -226.01

EV/EBIT

-51.74

Sector -49.26

Industry -49.26

P/EBITDA

3.08

Sector -21.23

Industry -21.23

P/EBIT

3.08

Sector -31.44

Industry -31.44

P/Total Assets

0.52

Sector 1.22

Industry 1.22

P/Net Current Assets

156.60

Sector -10.53

Industry -10.53

P/Working Capital

4.54

Sector -172.76

Industry -172.76

EPS

4.26

Sector -1.85

Industry -1.85

BVPS

7.74

Sector 2.00

Industry 2.00

Efficiency

Gross Margin

0.00%

Sector 40.67%

Industry 40.67%

EBITDA Margin

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

Sector -4,203,320.32%

Industry -4,203,320.32%

Operating Margin

0.00%

Sector -35.88%

Industry -35.88%

Net Profit Margins

0.00%

Sector -36.71%

Industry -36.71%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

55.08%

Sector -58.37%

Industry -58.37%

ROA

47.31%

Sector -61.30%

Industry -61.30%

ROIC

-3.27%

Sector -2,355.96%

Industry -2,355.96%

Dividends

Dividend yield

5.30%

Sector -

Industry -

Payout

5.88%

Sector -

Industry -

Debt

Current Ratio

4.98

Sector 2.88

Industry 2.88

Net Debt / EBITDA

18.51

Sector -14,081,727.47

Industry -14,081,727.47

Net Debt / EBIT

18.30

Sector -8.03

Industry -8.03

Net Debt / Equity

-0.16

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.86

Sector 0.45

Industry 0.45

Liabilities/Assets

0.14

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals ORMP

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Oramed Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$4.66

Fair Value

$27.24

Upside Return potential.

484.49%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ORMP Oramed Pharmaceuticals Inc.	$4.66	107.62%	5.30%	1.11	0.61	55.08%	0.00%
JNJ Johnson & Johnson	$265.58	52.53%	1.98%	30.47	7.54	24.76%	21.48%
PFE Pfizer Inc.	$27.72	24.31%	6.24%	35.93	1.84	5.11%	6.86%
ABBV AbbVie Inc.	$257.12	21.52%	2.65%	72.22	-76.87	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.07	-17.59%	4.32%	10.50	5.58	53.11%	35.32%
MRK Merck & Co. Inc.	$143.93	80.59%	2.33%	112.32	8.48	7.55%	4.76%
AZN AstraZeneca PLC	$160.17	2.40%	2.03%	19.00	4.89	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$63.64	44.28%	3.96%	13.95	5.80	41.55%	18.85%
ZTS Zoetis Inc.	$72.97	-49.82%	2.89%	11.41	9.59	84.02%	27.77%
AMGN Amgen Inc.	$377.35	40.29%	2.25%	26.93	20.14	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$781.49	40.10%	0.47%	18.62	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$107.20	39.40%	0.00%	30.46	87.77	288.13%	24.86%
MCK McKesson Corporation	$881.51	24.54%	0.37%	19.68	-26.99	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$515.44	30.65%	0.00%	29.63	6.45	21.76%	35.00%
CAH Cardinal Health Inc.	$234.57	56.04%	0.88%	31.71	-20.07	-63.29%	0.68%
ARGX argenx SE	$984.39	30.14%	0.00%	2.61	3.00	114.60%	44.55%
HRMY Harmony Biosciences Holdings Inc.	$41.52	28.19%	0.00%	13.26	2.41	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ORMP Historical Dividends

current DY: 5.30%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	01/15/2026	01/26/2026	0.25000000

ABOUT Oramed Pharmaceuticals

Oramed Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (2 people)

United States

24 years

Founded: 2002

2007

Time since IPO - 19 years

12

Employees

Oramed Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $193.71 million, with shareholders equity totaling $317.47 million.

The company employs approximately 12 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Oramed Pharmaceuticals Inc. reported $- in revenue, generating net income of $174.87 million.

Key financial metrics include a P/E ratio of 1.11, a price-to-book (P/B) ratio of 0.61, and a trailing twelve-month dividend yield of 5.30%.

The company trades under the ticker ORMP.

Market cap

$193.71 million

Net worth

$317.47 million

$317,473,000.00

Assets

$369.64 million

$369,643,000.00

Total Shares Outstanding

41.04 million

41,040,000

Average Daily Trading Volume

$204.61 Thousand

$204,614.00

Sector

Health Care

Industry

Biotechnology

ORMP

ORMP revenue and profits

Financial Results ORMP

DRAG THE FRAME TO SEE MORE DATA

ORMP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$881.51 24,54% (12M)

P/E

19.68

0.37%

ROE

-137.16%

P/BV

-26.99

CAH - Cardinal Health

$234.57 56,04% (12M)

P/E

31.71

0.88%

ROE

-63.29%

P/BV

-20.07

JNJ - Johnson & Johnson

$265.58 52,53% (12M)

P/E

30.47

1.98%

ROE

24.76%

P/BV

7.54

ABBV - AbbVie

$257.12 21,52% (12M)

P/E

72.22

2.65%

ROE

-106.44%

P/BV

-76.87

MRK - Merck & Co.

$143.93 80,59% (12M)

P/E

112.32

2.33%

ROE

7.55%

P/BV

8.48

AZN - AstraZeneca

$160.17 4,38% (12M)

P/E

19.00

2.03%

ROE

25.77%

P/BV

4.89

PFE - Pfizer

$27.72 24,31% (12M)

P/E

35.93

6.24%

ROE

5.11%

P/BV

1.84

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$881.51 24,54% (12 M)

P/L

19.68

0.37%

ROE

-137.16%

P/VP

-26.99

CAH - Cardinal Health

$234.57 56,04% (12 M)

P/L

31.71

0.88%

ROE

-63.29%

P/VP

-20.07

JNJ - Johnson & Johnson

$265.58 52,53% (12 M)

P/L

30.47

1.98%

ROE

24.76%

P/VP

7.54

ABBV - AbbVie

$257.12 21,52% (12 M)

P/L

72.22

2.65%

ROE

-106.44%

P/VP

-76.87

MRK - Merck & Co.

$143.93 80,59% (12 M)

P/L

112.32

2.33%

ROE

7.55%

P/VP

8.48

AZN - AstraZeneca

$160.17 4,38% (12 M)

P/L

19.00

2.03%

ROE

25.77%

P/VP

4.89

PFE - Pfizer

$27.72 24,31% (12 M)

P/L

35.93

6.24%

ROE

5.11%

P/VP

1.84

Frequently Asked Questions

What is the price of Oramed Pharmaceuticals (ORMP) today?

A cotação de Oramed Pharmaceuticals (ORMP) hoje está em US$ 4.66, com uma variação de 107.62% em relação ao último ano. A cotação de Oramed Pharmaceuticals (ORMP) iniciou o ano negociando na casa dos US$ 2.85 e hoje está em US$ 4.66. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Oramed Pharmaceuticals (ORMP) e dados de ações do Ibovespa e mercados internacionais.

Quando Oramed Pharmaceuticals (ORMP) paga dividendos?

No último ano, Oramed Pharmaceuticals (ORMP) distribuiu dividendos no mês de January, totalizando US$ 0.25. O Dividend Yield referente aos 12 últimos meses é de 5.30%.

Is Oramed Pharmaceuticals (ORMP) a good investment?

Atualmente, Oramed Pharmaceuticals (ORMP) está cotada a US$ 4.66, com um P/L de 1.11, representando um desvio de -251% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 107.62 em sua cotação e distribuiu US$ 0.25 em dividendos, resultando em um Dividend Yield de 5.30%. O retorno total do acionista foi de 107.62%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Oramed Pharmaceuticals (ORMP) stock?

Investir em ações de Oramed Pharmaceuticals (ORMP) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Oramed Pharmaceuticals (ORMP) yield today?

A rentabilidade de Oramed Pharmaceuticals (ORMP) foi de 4.72% no último mês, 107.62% no último ano e -74.27% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.25 em dividendos, um Dividend Yield de 5.30%.

Se você quisesse comprar 100 ações de Oramed Pharmaceuticals (ORMP) hoje, o investimento total seria de US$ 466.00, com base na cotação atual de US$ 4.66.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 967.51
Em 5 anos: US$ 119.90
Em 10 anos: US$ 313.39

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ORMP

Oramed Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ORMP

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING ORMP WITH OTHER STOCK

current DY: 5.30%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Oramed Pharmaceuticals

Oramed Pharmaceuticals Inc.

United States

24 years

2007

12

PROFIT X PRICE ORMP

Financial Results ORMP

ORMP cash flow

Asset, Revenue and Profit Growth - ORMP

ORMP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions